keyword
MENU ▼
Read by QxMD icon Read
search

Diosmin AND Leg edema

keyword
https://www.readbyqxmd.com/read/21274547/are-venotonic-drugs-effective-for-decreasing-acute-posttraumatic-oedema-following-ankle-sprain-a-prospective-randomized-clinical-trial
#1
RANDOMIZED CONTROLLED TRIAL
Elias Fotiadis, Eustathios Kenanidis, Efthimios Samoladas, Anastasios Chytas, Christos Lyrtzis, Miltiadis Koimtzis, Byron Chalidis
OBJECTIVE: Lower leg oedema after trauma may cause various degrees of pain, disability and delay in patient recovery. In this prospective randomized study, we hypothesized that venotonic drugs had no effect in clinical outcome of patients with ankle sprain. PATIENTS AND METHODS: Eighty-one patients with type II and III ankle sprain were screened and randomly assigned for receiving standard conservative treatment alone (control group, 39 patients) or with oral intake of a venotonic drug (micronized purified flavonoid fraction, Daflon 1,000 mg × 3) for 20 days (study group, 42 patients)...
March 2011: Archives of Orthopaedic and Trauma Surgery
https://www.readbyqxmd.com/read/16218350/-analysis-of-surgical-procedures-on-the-vena-saphena-magna-in-the-czech-republic-and-an-effect-of-detralex-during-its-stripping
#2
RANDOMIZED CONTROLLED TRIAL
L Veverková, J Kalac, V Jedlicka, J Wechsler
The aim of this clinical study was to compare the degree of postoperative pain (VAS--10 cm, quality of life questionnaire CIVIQ and patient diary) between two groups of patients: patients treated with Detralex 14 days before and 14 days after the stripping of greater saphenous vein (GSV) and patients not treated with Detralex. In addition, the two groups were also compared for the incidence of symptoms associated with chronic venous insufficiency (CVI) (using the VAS scale: edema, tired and heavy legs, cramps, itching sensation), size of hematoma, use of analgesics and overall efficacy of the treatment...
August 2005: Rozhledy V Chirurgii: Měsíčník Československé Chirurgické Společnosti
https://www.readbyqxmd.com/read/16193223/daflon-500-mg-symptoms-and-edema-clinical-update
#3
Albert-Adrien Ramelet
Patients suffering from any class of the Clinical, Etiological, Anatomical, Pathophysiological (CEAP) classification of chronic venous disease (CVD) may be symptomatic (C0s-C6s). Leg heaviness, discomfort, itching, cramps, pain, paresthesia, and edema (C3) are the most frequent manifestations of CVD and a major reason for medical consultation. Daflon 500 mg (micronized purified flavonoid fraction [MPFF]) is an effective treatment for symptoms and edema in CVD as demonstrated in several randomized controlled studies...
September 2005: Angiology
https://www.readbyqxmd.com/read/15678250/hr-0-beta-hydroxyethyl-rutosides-in-comparison-with-diosmin-hesperidin-in-chronic-venous-insufficiency-and-venous-microangiopathy-an-independent-prospective-comparative-registry-study
#4
RANDOMIZED CONTROLLED TRIAL
M R Cesarone, G Belcaro, L Pellegrini, A Ledda, A Di Renzo, G Vinciguerra, A Ricci, G Gizzi, E Ippolito, F Fano, M Dugall, G Acerbi, M Cacchio
The aim of this independent study was to investigate differences in efficacy between HR, (0-[beta-hydroxyethyl]-rutosides) and D+H (500 mg, diosmin+hesperidin) in patients with chronic venous insufficiency (CVI). A first group of 90 patients with severe venous hypertension (CVI, ankle swelling) were randomized into an HR or a D+H group. The HR group received oral HR (2 g/day, 8 weeks); the D+H group received a 500 mg tablet 3 times daily for 8 weeks. A second group of comparable patients was included in a registry following the same study format...
January 2005: Angiology
https://www.readbyqxmd.com/read/15641940/micronized-purified-flavonoid-fraction-mpff-a-review-of-its-pharmacological-effects-therapeutic-efficacy-and-benefits-in-the-management-of-chronic-venous-insufficiency
#5
REVIEW
Konstantinos Katsenis
Initially, the progression of chronic venous insufficiency is related to venous hypertension. The earliest complaints or symptoms, as well as vessel wall deterioration, valve restructuring, and, eventually, varicose veins, result not only from elevation of pressure, but also from a cascade of biochemical events related to both the macro- and the microcirculation. Thickening and remodelling of the venous wall are influenced by two parameters: abnormal shear stress and hypoxia that activate the endothelium first at the level of valve cusps and then in large veins...
January 2005: Current Vascular Pharmacology
https://www.readbyqxmd.com/read/12934756/from-skin-disorders-to-venous-leg-ulcers-pathophysiology-and-efficacy-of-daflon-500-mg-in-ulcer-healing
#6
REVIEW
Philip D Coleridge Smith
The standard treatments for venous diseases of the lower limb include compression bandaging and stockings as well as surgical removal of varicose veins. There are a number of conditions in which these conventional treatments are ineffective, particularly in the management of leg ulceration. Drug treatments for healing venous leg ulcers have yet to be developed to the stage of good clinical efficacy, but these may assist in the management of patients. Flavonoid drugs have been widely used in the management of the symptoms of venous disease for many years and have recently been studied in some detail to assess their effects on the microcirculation...
July 2003: Angiology
https://www.readbyqxmd.com/read/12934755/from-symptoms-to-leg-edema-efficacy-of-daflon-500-mg
#7
REVIEW
Andrew N Nicolaides
This article reviews the mechanisms by which micronized purified flavonoid fraction (MPFF; Daflon 500 mg) acts on symptoms as well as on edema in patients with chronic venous disease, in the light of new advances in the understanding of the pathophysiology of this chronic condition. Deterioration of venous wall tone followed by valve dysfunction leading eventually to varicose veins are the key pathophysiologic features that produce venous hypertension. Both mechanical and biological factors are responsible for the deterioration of the venous wall in large veins...
July 2003: Angiology
https://www.readbyqxmd.com/read/12025911/chronic-venous-insufficiency-worldwide-results-of-the-relief-study-reflux-assessment-and-quality-of-life-improvement-with-micronized-flavonoids
#8
MULTICENTER STUDY
G Jantet
Chronic venous insufficiency (CVI) results in considerable morbidity and may seriously affect patients' quality of life. The RELIEF (Reflux assEssment and quaLity of life improvEment with micronized Flavonoids) Study was a prospective controlled study designed to assess differences in the severity and in the evolution of symptoms and signs of CVI according to presence or not of venous reflux. Patients were thus separated into 2 comparative groups: those presenting venous reflux and those without venous reflux...
May 2002: Angiology
https://www.readbyqxmd.com/read/11510597/clinical-benefits-of-daflon-500-mg-in-the-most-severe-stages-of-chronic-venous-insufficiency
#9
REVIEW
A A Ramelet
Chronic venous insufficiency (CVI) affects a large number of people in Western countries, and is responsible for considerable inconvenience, discomfort, suffering, and costs. Micronized purified flavonoid fraction (MPFF, 450 mg diosmin plus 50 mg hesperidin-Daflon 500 mg) is a potent venotropic drug used in the treatment of venous insufficiency. Pharmacological and clinical studies demonstrated the comprehensive mode of action of Daflon 500 mg: it increases venous tone, it improves lymph drainage, and it protects the microcirculation...
August 2001: Angiology
https://www.readbyqxmd.com/read/10811522/therapeutic-efficacy-of-flavonoids-in-oedema-following-reperfusion-on-acutely-ischaemic-legs
#10
RANDOMIZED CONTROLLED TRIAL
K A Filis, S E Georgopoulos, S C Papas, V Votteas, E A Bastounis
BACKGROUND: The aim of this study was to investigate the effect of a purified, micronised, flavonoid fraction (Daflon) in lower limb oedema developed after delayed embolectomy and successful reperfusion of acutely ischaemic legs. METHODS: Our series consisted of 19 patients with prolonged, acute ischaemia of the lower extremity caused by arterial embolism, who had undergone successful embolectomy. Patients were randomised into two groups; ten patients (group I) treated with flavonoids, were compared to nine given a placebo...
December 1999: International Angiology: a Journal of the International Union of Angiology
https://www.readbyqxmd.com/read/10667641/relief-study-first-consolidated-european-data-reflux-assessment-and-quality-of-life-improvement-with-micronized-flavonoids
#11
MULTICENTER STUDY
G Jantet
The RELIEF study (Reflux assEssment and quality of life improvement with micronized Flavonoids in chronic venous insufficiency [CVI]) is a prospective, controlled, multicenter, international study performed in patients with or without venous reflux. This study was conducted between March 1997 and December 1998 in 23 countries worldwide with the participation of more than 10,000 patients suffering from CVI. The European countries, the subject of this report, were represented by the Czech and Slovak Republics, Hungary, Poland, Russia, and Spain...
January 2000: Angiology
https://www.readbyqxmd.com/read/10667638/management-of-venous-edema-insights-from-an-international-task-force
#12
D L Clement
An International Task Force made up of a panel of 16 experts has reviewed and objectively evaluated all aspects of chronic venous disease of the leg (CVDL). All available publications on CVDL from 1983 to 1997 were identified through computerized search in Medline and by a manual search. Next, three different screenings were performed in order to select only relevant papers providing a level of scientific evidence that was considered moderate to strong. Final conclusions and further therapeutic recommendations were made based on these publications...
January 2000: Angiology
https://www.readbyqxmd.com/read/9477039/postischemic-leukocyte-endothelial-cell-interactions-and-microvascular-barrier-dysfunction-in-skeletal-muscle-cellular-mechanisms-and-effect-of-daflon-500-mg
#13
REVIEW
R J Korthuis, D C Gute
A growing body of evidence indicates that neutrophils play a critical role in disrupting the microvascular barrier in skeletal muscle. Recent studies from our laboratory and by others indicate that administration of antibodies directed against P-selectin, ICAM-1, or the common subunit (CD18) of CD11/CD18 was as effective as neutrophil depletion in attenuating ischemia/reperfusion (I/R)-induced microvascular barrier disruption and edema formation in skeletal muscle. These studies have important implications with regard to the pathogenesis of leg ulceration in view of our more recent work indicating that the increase in tissue pressure induced by edema formation secondary to microvascular barrier disruption may lead to the development of capillary no-reflow...
1997: International Journal of Microcirculation, Clinical and Experimental
https://www.readbyqxmd.com/read/4083175/the-effects-of-diosmin-a-benzo-pyrone-upon-some-high-protein-oedemas-lung-contusion-and-burn-and-lymphoedema-of-rat-legs
#14
J R Casley-Smith, J R Casley-Smith
Oral diosmin (a benzo-pyrone) was used to treat rats with contused lungs, in doses of 50 or 200 mg/kg/day. The contusion was produced by direct trauma. The lungs were examined with the electron microscope, both qualitatively and quantitatively, at 1, 2 and 4 days. It was found that diosmin considerably reduced interstitial oedema and tissue disorganization. The concentration of protein, both in the interstitial tissue and in the air spaces, was also much reduced. There was a greater effect at the higher dosage than at the lower one...
October 1985: Agents and Actions
https://www.readbyqxmd.com/read/3059075/the-pathophysiology-of-lymphedema-and-the-action-of-benzo-pyrones-in-reducing-it
#15
REVIEW
J R Casley-Smith, J R Casley-Smith
The pathogenesis of lymphedema is briefly reviewed. Swelling secondary to lymphostasis shares the common deleterious effects of other edemas, especially those of chronic high protein edema, namely chronic inflammation with excess tissue fibrosis. Benzo-pyrones are the only known drugs which reduce the excess protein in the tissues with high protein edema including lymphedema. Once excess tissue protein is resorbed, edema subsides and the fibrosis slowly resolves by remodeling. Two of these benzo-pyrone drugs have been shown to reduce postmastectomy and primary lymphedema in randomized, double-blind, cross-over, placebo-controlled trials...
September 1988: Lymphology
https://www.readbyqxmd.com/read/2698902/are-the-phlebotonic-properties-shown-in-clinical-pharmacology-predictive-of-a-therapeutic-benefit-in-chronic-venous-insufficiency-our-experience-with-daflon-500-mg
#16
RANDOMIZED CONTROLLED TRIAL
Y Tsouderos
In 3 controlled clinical trials, double blind versus placebo, the activity of Daflon 500 mg, a new micronised flavonoid fraction, has been evaluated on venous tone using venous plethysmography. A double-blind, randomized cross-over Phase II pharmaco-clinical trial has shown that Daflon 500 mg is statistically more effective than placebo on pathological legs, as well as normal legs. In this study, which included 20 patients suffering from post-thrombotic syndrome, Daflon 500 mg decreased: 1) venous capacity (p less than 0...
October 1989: International Angiology: a Journal of the International Union of Angiology
https://www.readbyqxmd.com/read/1633720/therapeutic-effects-of-hidrosmin-on-chronic-venous-insufficiency-of-the-lower-limbs
#17
RANDOMIZED CONTROLLED TRIAL
C Domínguez, I Brautigam, E González, J A González, J Nazco, R Valiente, J Boada
A double-blind, placebo-controlled trial was carried out to assess the effectiveness of a new synthetic bioflavonoid, hidrosmin, in patients with chronic venous insufficiency of the lower limbs. Fifty-seven patients, showing varicose veins and ankle swelling and suffering from local pain and heaviness of the legs, were allocated at random to receive treatment for 45 days with 1 capsule 3-times daily of either 200 mg hidrosmin (30 patients) or placebo (27 patients). Pain and heavy legs were assessed using rating scales; swelling was assessed by a photographic method...
1992: Current Medical Research and Opinion
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"